Extendicare (TSE:EXE – Get Free Report) had its target price lifted by analysts at Royal Bank of Canada from C$9.50 to C$11.00 in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 4.46% from the company’s previous close.
Separately, TD Securities lifted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a report on Thursday, November 14th.
Read Our Latest Analysis on Extendicare
Extendicare Price Performance
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- What Are Some of the Best Large-Cap Stocks to Buy?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What are earnings reports?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Manufacturing Stocks Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.